In the competitive landscape of drug development, particularly within the burgeoning field of microbiome and live biotherapeutic research, stability data is the foundation of product quality and regulatory acceptance. Whether you are developing a targeted probiotic supplement or a complex Live Biotherapeutic Product (LBP) for clinical trials, understanding how your microbial consortia behave over time is non-negotiable.
As a specialized CRO, Creative Biolabs offers a high-precision platform dedicated to assessing the shelf-life and biological integrity of microbial products. Our services are designed to bridge the gap between initial strain characterization and final product commercialization, ensuring that the "live" in your biotherapeutic remains a reality until the moment of consumption.
Understanding Stability in the Context of Live Biotherapeutics
Stability testing for traditional small-molecule drugs focuses on chemical degradation. For LBPs, the focus shifts to biological viability. A "stable" live biotherapeutic must not only retain a specific concentration of colony-forming units (CFU) but must also maintain its metabolic activity, phenotypic characteristics, and genomic stability under various environmental stressors.
We categorize our testing into two distinct but complementary phases: Informal (Exploratory) Stability and Formal (Regulatory-Compliant) Stability. The former allows for rapid iteration during early-stage development, while the latter provides the validated data necessary for Investigational New Drug (IND) or Biologics License Application (BLA) submissions.
Our Comprehensive Service Portfolio
Our service is structured to support you at every stage of the drug development lifecycle, from initial formulation screening to final product release.
Test Types
Testing Methods
Sample Types
Deliverables
Turnaround Time
Stability Test Types
The longevity of a microbial product is determined by its ability to withstand environmental stress. We utilize four distinct types of stability testing methods to provide a complete picture of your product's lifecycle:
-
Regular (Real-Time) Stability Test: Conducted at the recommended storage temperature (e.g., 5±3℃, 25±2℃) for the duration of the intended shelf life. This establishes the definitive expiration date.
-
Accelerated Stability Test: Samples are subjected to exaggerated conditions, typically 40±2℃ and 75%±5% RH for 6 months. This predicts long-term stability and identifies potential degradation pathways quickly.
-
Intermediate Stability Test: Performed at 30±2℃ and 65%±5% RH. If significant changes occur during accelerated testing, provide a data buffer for room-temperature storage justifications.
-
Forced Degradation (Stress Testing): Used during R&D to understand intrinsic stability by exposing strains to extreme heat, pH shifts, and photostability challenges.
Testing Methods
-
Viability Assessment:
-
Culture-Based Methods: Traditional CFU counting to determine actively replicating populations.
-
Flow Cytometry: Advanced Live/Dead staining to detect viable but non-culturable (VBNC) cells at the single-cell level.
-
PMA-PCR/qPCR: Implementation of viability-dye pretreatment (Propidium Monoazide) to selectively quantify DNA from cells with intact membranes.
-
Identity and Purity: Using 16S rRNA sequencing and Whole Genome Sequencing (WGS), we ensure that no genetic drift occurs and that the product remains free from contaminants.
-
Metabolic Profiling: We measure relevant metabolites (such as short-chain fatty acids or specific enzymes) to confirm that the bacteria are still functionally active.
-
Physicochemical Testing: Monitoring moisture content, water activity, and encapsulation integrity for lyophilized or coated products.
Sample Types
We accommodate a wide range of LBP formats, including:
-
Bulk drug substances and active pharmaceutical ingredients (API).
-
Finished dosage forms: capsules, tablets, powders, and liquids.
-
Encapsulated or coated formulations designed for targeted intestinal release.
Deliverables
Transparency and data integrity are our priorities. For every project, customers receive:
-
Comprehensive Stability Reports: Detailed analysis of data trends over time.
-
Degradation Kinetic Modeling: Statistical predictions of shelf life.
-
Certificates of Analysis (CoA): Validated results for each testing interval.
-
Raw Data Packages: Complete documentation for regulatory audits.
Turnaround Time
We recognize that drug development is a race against time.
-
Informal Studies: Results for accelerated stress testing (e.g., a 4-week "forced degradation" study) can typically be delivered within 6 to 8 weeks.
-
Formal Studies: These are dictated by the ICH timelines (6 months, 12 months, 24 months, or longer). However, we provide Interim Reports at every testing interval (e.g., 1, 3, and 6 months) so you can make informed decisions about your clinical trials without waiting for the final report.
Platform Advantages: Why Choose Us?
Choosing a CRO partner for live biotherapeutics requires a team that speaks the language of microbiology. Our platform offers several key advantages:
Specialized Anaerobic Expertise
Many LBPs are highly sensitive to oxygen. Our entire workflow, from sampling to analysis, can be conducted within specialized anaerobic chambers to prevent oxidative stress and false-negative viability results.
Customized Method Validation
We don't believe in one-size-fits-all. We develop and validate strain-specific assays tailored to the unique growth requirements of your specific microorganism.
Integrated Ecosystem
Because we also provide preclinical research products, we can seamlessly transition your project from initial strain isolation and characterization into formal stability testing.
Application Fields
Our stability services are critical for various sectors within the life sciences:
-
Drug Development: Establishing the CMC (Chemistry, Manufacturing, and Controls) section for IND/NDA applications of LBPs.
-
Probiotic Commercialization: Validating the "guaranteed potency at expiration" for high-end dietary supplements.
-
Formulation Science: Comparing the protective effects of different cryoprotectants or encapsulation technologies.
The path to bringing a Live Biotherapeutic Product to market is paved with technical hurdles, none more critical than ensuring the "life" remains in the biotherapeutic. By partnering with a CRO that lives and breathes microbiome science, you gain more than just a data provider; you gain a strategic ally dedicated to the integrity of your science. Our rigorous stability testing protocols ensure that when your product finally reaches the patient, it is as potent and effective as the day it was formulated.
Would you like me to draft a specific stability testing protocol for a particular microbial strain or formulation type you are currently developing?
Frequently Asked Questions (FAQs)
What is the difference between informal and formal stability testing?
Informal testing is "exploratory." It uses non-validated methods to quickly assess how different formulations or packaging options affect the bacteria. Formal testing is "regulatory." It uses validated methods under strict quality controls to generate the data used for official shelf-life claims.
How do you handle microorganisms that are difficult to culture?
For "unculturable" or fastidious strains, we rely heavily on molecular methods like qPCR and membrane integrity stains via flow cytometry to ensure we are capturing an accurate picture of the living population.
Can you perform "In-Use" stability testing?
Yes. We can simulate the conditions the product will face after the consumer opens the package, ensuring the product remains viable during the typical duration of a treatment course.
